William Blair Upgrades ResMed (RMD) to Outperform
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $219.66 -0.13%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Join SI Premium – FREE
William Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $47.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Clean Harbors (CLH) at Outperform, Adds to Conviction List, 'New Top Pick in Waste'
- Goldman Sachs Upgrades Harbour Energy PLC (HBR:LN) to Buy
- Wolfe Research Upgrades Kymera Therapeutics (KYMR) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
